Multiple Sclerosis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are an adult aged between 18 and 45 years old (male or female)
- You are covered by health insurance
- You have read, understood, and freely signed a consent form agreeing to take part
- (For patients only) You have been diagnosed with relapsing-remitting multiple sclerosis (a form of MS with flare-ups and periods of recovery) based on specific diagnostic guidelines (McDonald 2010 criteria)
- (For patients only) You have had MS for less than 5 years
- (For patients only) You may or may not currently be taking a first-line MS medication
- (For patients only) At least one active area of inflammation was found on your initial brain MRI scan using a contrast dye called Gadolinium
Who may not be able to join:
- (For patients only) You have a progressive form of MS (such as primary progressive or secondary progressive MS), rather than the relapsing-remitting form
- You have a medical reason that prevents you from having an MRI scan, such as a pacemaker, metal fragments in your body, or severe claustrophobia (fear of enclosed spaces)
- You have difficulties that might make it hard to complete the exam, such as trouble understanding instructions, confusion, uncontrolled movements, or difficulty lying still for a long period of time
- You are unable to give informed consent due to difficulties with understanding, reduced alertness, or confusion
- You are currently pregnant or breastfeeding
- You have a history of a neurological (brain or nerve) or psychiatric (mental health) condition
- You are under legal guardianship or a similar supervised care arrangement
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: EMILIE GARRIDO PRADALIE, APHM
Phone: +33 491388204
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
ihMTR ratio at 1.5TMRI; Magnetic transfert (MT) at 1.5TMRI; Myelin water fraction at 1.5TMRI
Can't join this trial?
Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.